These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28755382)

  • 1. Tools to define the melanoma-associated immunopeptidome.
    Bräunlein E; Krackhardt AM
    Immunology; 2017 Dec; 152(4):536-544. PubMed ID: 28755382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.
    Engelhard VH; Bullock TN; Colella TA; Mullins DW
    Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo anti-melanoma activities of the Melan-A/MART-1(101-115) T CD4+ cell peptide.
    Balasse E; Gatouillat G; Patigny D; Andry MC; Madoulet C
    Vaccine; 2009 Oct; 27(44):6107-9. PubMed ID: 19686694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
    Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
    Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of melanoma antigen expression in cancer therapy.
    Gillespie AM; Coleman RE
    Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
    Ghorani E; Rosenthal R; McGranahan N; Reading JL; Lynch M; Peggs KS; Swanton C; Quezada SA
    Ann Oncol; 2018 Jan; 29(1):271-279. PubMed ID: 29361136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
    Röhn TA; Reitz A; Paschen A; Nguyen XD; Schadendorf D; Vogt AB; Kropshofer H
    Cancer Res; 2005 Nov; 65(21):10068-78. PubMed ID: 16267033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: dendritic cell immunotherapy for melanoma.
    Hadzantonis M; O'Neill H
    Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
    Prins RM; Odesa SK; Liau LM
    Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-associated tumor antigens and their clinical relevance to immunotherapy.
    Gattoni-Celli S; Cole DJ
    Semin Oncol; 1996 Dec; 23(6):754-8. PubMed ID: 8970598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy.
    Rivoltini L; Loftus DJ; Barracchini K; Arienti F; Mazzocchi A; Biddison WE; Salgaller ML; Appella E; Parmiani G; Marincola FM
    J Immunol; 1996 May; 156(10):3882-91. PubMed ID: 8621927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melanoma antigen genes(MAGE) and malignant tumors].
    Xu JZ; Lin S
    Ai Zheng; 2003 Sep; 22(9):1001-4. PubMed ID: 12969539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.
    Imro MA; Dellabona P; Manici S; Heltai S; Consogno G; Bellone M; Rugarli C; Protti MP
    Hum Gene Ther; 1998 Jun; 9(9):1335-44. PubMed ID: 9650618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
    van Buuren MM; Dijkgraaf FE; Linnemann C; Toebes M; Chang CX; Mok JY; Nguyen M; van Esch WJ; Kvistborg P; Grotenbreg GM; Schumacher TN
    J Immunol; 2014 Jan; 192(2):641-8. PubMed ID: 24342804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rejection antigens of tumors and specific immunotherapy of cancer].
    Boon T; Lucas S
    Bull Mem Acad R Med Belg; 1996; 151(12):469-79. PubMed ID: 9491625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
    Kirkin AF; Dzhandzhugazyan K; Zeuthen J
    Exp Clin Immunogenet; 1998; 15(1):19-32. PubMed ID: 9619397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma.
    Faridi P; Woods K; Ostrouska S; Deceneux C; Aranha R; Duscharla D; Wong SQ; Chen W; Ramarathinam SH; Lim Kam Sian TCC; Croft NP; Li C; Ayala R; Cebon JS; Purcell AW; Schittenhelm RB; Behren A
    Cancer Immunol Res; 2020 Oct; 8(10):1322-1334. PubMed ID: 32938616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
    Zhang X; Qi Y; Zhang Q; Liu W
    Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome.
    Lv D; Chang Z; Cai Y; Li J; Wang L; Jiang Q; Xu K; Ding N; Li X; Xu J; Li Y
    Nucleic Acids Res; 2022 Jan; 50(D1):D413-D420. PubMed ID: 34570220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.